Skip to content

A research study looking at how different doses of study medicine (Inno8) works in the body of healthy men.

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-506520-90-00
Acronym
NN7442-7582
Enrollment
108
Registered
2024-09-16
Start date
2024-09-16
Completion date
Unknown
Last updated
2025-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prophylaxis and on-demand treatment respectively in patients with haemophilia A with or without FVIII inhibitors.

Interventions

None listed

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026